Skip to main content
Erik Roberson, MD, Neurology, Birmingham, AL

ErikD.RobersonMDPhD

Neurology • Birmingham, AL

Neurodegenerative, Dementia & Geriatrics

Rebecca Gale Endowed Professor; Director, Alzheimer's Disease Center; Director, Center for Neurodegeneration and Experimental Therapeutics

Join to view full profile

Dr. Roberson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Roberson's full profile

Already have an account?

  • Office

    1717 6th Ave S
    Birmingham, AL 35233
    Phone+1 800-822-8816
    Fax+1 205-975-7365

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Neurology, 2000 - 2003
  • Baylor College of Medicine
    Baylor College of MedicineInternship, Transitional Year, 1999 - 2000
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1999

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2001 - Present
  • AL State Medical License
    AL State Medical License 2008 - 2025
  • American Board of Psychiatry and Neurology Neurology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-Insufficient Mice  
    Erik Roberson, MD, ScienceDirect

Press Mentions

  • Gift Advances Alzheimer’s Disease Research
    Gift Advances Alzheimer’s Disease ResearchJanuary 17th, 2023
  • $5 Million Gift to UAB Will Support Alzheimer’s Disease Research
    $5 Million Gift to UAB Will Support Alzheimer’s Disease ResearchOctober 31st, 2022
  • Will Reduction in Tau Protein Protect Against Parkinson’s and Lewy Body Dementias?
    Will Reduction in Tau Protein Protect Against Parkinson’s and Lewy Body Dementias?June 18th, 2021
  • Join now to see all

Grant Support

  • Mechanisms For The Benefit Of TAU Reduction In Alzheimer Disease ModelsNational Institute Of Neurological Disorders And Stroke2011–2012
  • Mechanisms For TAU Involvement In Alzheimer'S DiseaseNational Institute Of Neurological Disorders And Stroke2008–2010
  • Mechanisms For TAU Involvement In Alzheimer'S DiseaseNational Institute Of Neurological Disorders And Stroke2006–2008

Dr. Erik Roberson, Dr. Erik Roberson, MD, Dr. E Roberson, Dr. Erik D. Roberson